Human prostate-specific glandular kallikrein is expressed as an active and an inactive protein

Clinical Chemistry

Volumn 43, Issue 2, 1997, Pages 279-284

  Herrala, Annakaisa ^a   Kurkela, Riitta ^a   Porvari, Katja ^a   Isomäki, Ritva ^a   Henttu, Pirkko ^a   Vihko, Pirkko ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

allelic frequency; enzyme activity; polymorphism; prostate specific antigen; prostatic cancer; purification of assay components; recombinant protein

Indexed keywords

CHYMOTRYPSIN; DNA; KALLIKREIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; RECOMBINANT PROTEIN; TRYPTASE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; MALE; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION;

INSECTA;

EID: 0031013194     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.2.279     Document Type: Article

References (47)

1. Clements JA. The glandular kallikrein family of enzymes: tissue-specific expression and hormonal regulation. Endocrine Rev 1989;10:393-419.
2. Evans BA, Yun ZX, Close JA, Tregear GW, Kitamura N, Nakanishi S, et al. Structure and chromosomal localization of the human renal kallikrein gene. Biochemistry 1988;27:3124-9.
3. Riegman PHJ, Vliestra RJ, Klaassen P, van der Korput JAGM, Romijn JC, Trapman J. The prostate specific antigen gene and the human glandular kallikrein-1 gene are tandemly located on chromosome 19. FEBS Lett 1989;247:123-6.
4. Riegman PHJ, Vliestra RJ, Suurmeijer L, Cleutjens CB, Trapman J. Characterization of the human kallikrein locus. Genomics 1992; 14:6-11.
5. Henttu P, Vihko P. cDNA coding for the entire human prostate specific antigen shows high homologies to the human tissue kallikrein genes. Biochem Biophys Res Commun 1989;160:903-10.
6. Henttu P, Vihko P. Prostate-specific antigen and human glandular kallikrein: two kallikreins of the human prostate. Ann Med 1994; 26:157-64.
7. Baker AR, Shine J. Human kidney kallikrein: cDNA cloning and sequence analysis. DNA 1985;4:445-50.
8. Fukushima D, Kitamura N, Nakanishi S. Nucleotide sequence of cloned cDNA from human pancreatic kallikrein. Biochemistry 1985;24:8037-43.
9. Angermann A, Bergmann C, Appelhans H. Cloning and expression of human salivary-gland kallikrein in Escherichia coli. Biochem J 1989;262:787-93.
10. Chapdelaine P, Paradis G, Tremblay RR, Dubé JY. High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen. FEBS Lett 1988;236:205-8.
11. Qiu S-D, Young CY-F, Bilhartz DL, Prescott JL, Farrow GM, He W-W, Tindall DJ. In situ hybridization of prostate-specific antigen mRNA in human prostate. J Urol 1990;144:1550-6.
12. Young CY-F, Andrews PE, Montgomery BT, Tindall DJ. Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein. Biochemistry 1992;31:818-24.
13. Hakalahti L, Vihko P, Henttu P, Autio-Harmainen H, Soini Y, Vihko R. Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic cancer using Northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies. Int J Cancer 1993;55:590-7.
14. Henttu P, Liao S, Vihko P. Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCap cell line. Endocrinology 1992;130:766-72.
15. Henttu P, Vihko P. Growth factor regulation of gene expression in the human prostatic cancer cell line LNCaP. Cancer Res 1993; 53:1051-8.
16. Clements J, Mukhtar A. Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium. J Clin Endocrinol Metab 1994;78:1536-9.
17. Yu H, Diamandis EP. Prostate-specific antigen in milk of lactating women. Clin Chem 1995;41:54-8.
18. Yu D, Diamandis EP, Sutherland DJA. Immunoreactive prostate specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 1994;27:75-9.
19. Yu H, Diamandis EP, Nostratollah Z, Grass L. Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines. Breast Cancer Res Treat 1994;32:291-300.
20. Diamandis EP, Yu H, Sutherland DJA. Detection of prostate-specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat 1994;32:301-10.
21. Yu H, Diamandis EP, Monne M, Croce CM. Oral contraceptive-induced expression of prostate-specific antigen in the female breast. J Biol Chem 1995;270:6615-8.
22. Schedlich L, Bennets BH, Morris BJ. Primary structure of a human glandular kallikrein gene. DNA 1987;6:429-37.
23. Schaller J, Akiyama K, Tsuda R, Hara M, Marti T, Rickli EE. Isolation, characterization and amino-acid sequence of γ-seminoprotein, a glycoprotein from human seminal plasma. Eur J Biochem 1987;170:111-20.
24. Watt KWK, Lee P-J, M'Timkulu T, Chan W-P, Loor R. Human prostate-specific antigen: structural and funtional similarity with serine proteases. Proc Natl Acad Sci U S A 1986;83:3166-70.
25. Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985;76: 1899-903.
26. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab 1992;75:1046-53.
27. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostatic-specific antigen as a serum marker for adenocancer of the prostate. N Engl J Med 1987;317:909-16.
28. Vihko P, Kurkela R, Ramberg J, Pelkonen I, Vihko R. Time-resolved immunofluorometric assay of human prostate-specific antigen. Clin Chem 1990;36:92-5.
29. Bélanger A, van Halbeek H, Graves HCB, Grandbois K, Stamey TA, Huang L, et al. Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard. Prostate 1995;27:187-97.
30. Saedi MS, Gass MMJ, Goel AS, Grauer L, Hogen KL, Okaneya T, et al. Overexpression of human prostate-specific glandular kallikrein, hK2, in E. coli and generation of antibodies. Mol Cell Endocrinol 1995;109:237-41.
31. Sanger F, Nicklen S, Coulson AP. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 1977;74:5463-7.
32. Vandenplas S, Wiid I, Grobler-Rabie A, Brebner K, Ricketts M, Wallis G, et al. Blot hybridization of genomic DNA. J Med Genet 1984;21:164-72.
33. Elo J, Kvist L, Leinonen K, Isomaa V, Henttu P, Lukkarinen O, et al. Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol. J Clin Endocrinol Metab 1995;80:3494-500.
34. Summers MD, Smith GE. A manual of methods for baculovirus vectors and insect cell culture procedures. Tex Agric Exp Stn Bull 1987;1555:26-8.
35. Vihko P, Kurkela R, Porvari K, Herrala A, Lindfors A, Lindqvist Y, et al. Rat acid phosphatase: overexpression of active, secreted enzyme by recombinant baculovirus infected insect cells. Proc Natl Acad Sci USA 1993;90:799-803.
36. Jovin TM. Multiphasic zone electrophoresis. I. Steady-state moving boundary systems formed by different electrolyte combinations. Biochemistry 1973;12:871-90.
37. Wyckoff M, Rodbard D, Crambach A. Polyacrylamide gel electrophoresis in sodium dodecyl sulphate containing buffers using multiphasic buffer systems: properties of the stack, valid Rf measurements and optimized procedure. Anal Biochem 1977;78: 459-82.
38. Davis BJ. Disc electrophoresis II: methods and application to human serum proteins. Ann N Y Acad Sci 1964;121:404-27.
39. Andrews AT. Molecular weight measurement and the use of gel concentration gradients. In: Electrophoresis. Theory, techniques and biochemical and clinical applications. Oxford, UK: Clarendon Press, 1981:63-80.
40. Heukeshoven J, Dernick R. Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining. Electrophoresis 1985;6:103-12.
41. Prieur B, Russo-Marie F. An automated Western blot analysis using the Phast System. Anal Biochem 1988;172:338-43.
42. Akiyama K, Nakamura T, Iwanaga S, Hara M. The chymotrypsin-like activity of human prostate-specific antigen, γ-seminoprotein. FEBS Lett 1987;225:168-72.
43. Kurkela R, Herrala A, Henttu P, Nal H, Vihko P. Expression of active, secreted human prostate-specific antigen by recombinant baculovirus-infected insect cells on a pilot-scale. Bio/Technology 1995;13:1230-4.
44. Huber PR, Schmid H-P, Mattarelli G, Strittmatter B, van Steenbrugge GJ, Maurer A. Serum free prostate specific antigen: isoenzymes in benign hyperplasia and cancer of the prostate. Prostate 1995;27:212-9.
45. Christensson A. Laurell CB, Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 1990;194:755-63.
46. Zhang W-M, Leinonen J, Kalkkinen N, Dowell B, Stenman U-H. Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid. Clin Chem 1995;41:1567-73.
47. Fichtner J, Graves HCB, Thatcher K, Yemoto C, Shortliffe LMD. Prostate specific antigen releases a kinin-like substance on proteolysis of seminal vesicle fluid that stimulates smooth muscle contraction. J Urol 1996;155:738-42.